Gilead execs bag pay hikes, $8 million in bonuses By: San Francisco Business Times via Business Journals January 30, 2014 at 19:30 PM EST While facing cries that its cutting-edge hepatitis and HIV drugs are overpriced, Gilead Sciences Inc... Read More >> Related Stocks: Bristol-Myers Squibb